BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32915373)

  • 21. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
    Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
    World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
    Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
    Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment and validation of a nomogram for predicting prognosis of gastric neuroendocrine neoplasms based on data from 490 cases in a single center].
    Zhang B; Lu Y; Li L; Gao Y; Liang W; Xi H; Wang X; Zhang K; Chen L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):183-190. PubMed ID: 36946036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients.
    Li L; Zeng Q; Xue N; Wu M; Liang Y; Xu Q; Feng L; Xing S; Chen S
    Cancer Control; 2020; 27(1):1073274820954458. PubMed ID: 32959672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.
    Wang S; Chen C; Zhang J; Li J; Qin Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10293-10305. PubMed ID: 37270732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
    Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
    Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
    Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram to Predict Recurrence and Guide a Pragmatic Surveillance Strategy After Resection of Hepatoid Adenocarcinoma of the Stomach: A Retrospective Multicenter Study.
    Lin JX; Lin JP; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Li P; Wang ZK; Zheng CH; Huang CM; Xie JW
    Ann Surg Oncol; 2023 May; 30(5):2942-2953. PubMed ID: 36352297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.
    Pulvirenti A; Javed AA; Landoni L; Jamieson NB; Chou JF; Miotto M; He J; Gonen M; Pea A; Tang LH; Nessi C; Cingarlini S; D'Angelica MI; Gill AJ; Kingham TP; Scarpa A; Weiss MJ; Balachandran VP; Samra JS; Cameron JL; Jarnagin WR; Salvia R; Wolfgang CL; Allen PJ; Bassiy C
    Ann Surg; 2021 Dec; 274(6):1051-1057. PubMed ID: 31567347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
    Hirabayashi S; Kosugi S; Isobe Y; Nashimoto A; Oda I; Hayashi K; Miyashiro I; Tsujitani S; Kodera Y; Seto Y; Furukawa H; Ono H; Tanabe S; Kaminishi M; Nunobe S; Fukagawa T; Matsuo R; Nagai T; Katai H; Wakai T; Akazawa K
    Ann Oncol; 2014 Jun; 25(6):1179-84. PubMed ID: 24669009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
    Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resection.
    Shang-Guan XC; Chen QY; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH
    Surg Oncol; 2018 Mar; 27(1):54-60. PubMed ID: 29549904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of nomogram for disease free survival for colon cancer in UK population: A prospective cohort study.
    Kazem MA; Khan AU; Selvasekar CR
    Int J Surg; 2016 Mar; 27():58-65. PubMed ID: 26796369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
    Chen J; Wang A; Ji K; Bu Z; Ji J
    BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
    Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
    Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis.
    Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    Ann Surg Oncol; 2020 Oct; 27(10):3717-3726. PubMed ID: 32436187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.
    Chen D; Jiang B; Xing J; Liu M; Cui M; Liu Y; Wang Z; Chen L; Yang H; Zhang C; Yao Z; Zhang N; Ji J; Qu H; Su X
    PLoS One; 2013; 8(10):e76041. PubMed ID: 24146811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nomogram for predicting recurrence after complete resection for thymic epithelial tumors based on the TNM classification: A multi-institutional retrospective analysis.
    Yun JK; Lee GD; Kim HR; Kim DK; Zo JI; Shim YM; Kang CH; Kim YT; Paik HC; Chung KY;
    J Surg Oncol; 2019 Jun; 119(8):1161-1169. PubMed ID: 30919992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.